"All the World's a Stage We Pass Through" R. Ayana

Showing posts with label albert hofmann. Show all posts
Showing posts with label albert hofmann. Show all posts

Wednesday, 16 September 2015

Psychedelic Scientists


Psychedelic Scientists

Albert Hofmann and the Human Recondition by R. Ayana






“The most beautiful experience we can have is the mysterious. It is the fundamental emotion that stands at the cradle of true art and true science. Whoever does not know it and can no longer wonder, no longer marvel, is as good as dead, and his eyes are dimmed.”
– Albert Einstein


Psychedelics and related substances have contributed to a number of major scientific and technological breakthroughs and developments. Their highly ill-informed designation as Class A substances “with a high potential for abuse and no medical use” stands in stark contrast to what the accumulating scientific evidence has to say about these compounds.

A much neglected area of psychedelic science, ironically, is how psychedelics contribute to the creative scientific process. Outlawing psychedelics – as well as depriving people of medicines and therapeutic aids – is also depriving people of profoundly useful tools to enhance the creative, problem solving process.

A number of scientists have been open about their psychedelic use, but such people are likely to be in a profound minority, with others fearing repercussions for their honesty. It goes without saying how influential psychedelics were to the thinking of Harvard University psychologists Tim Leary, Richard Alpert and Ralph Metzner. Research was initially conducted with psilocybin, and in a more ordered scientific context, but LSD appeared on the scene and events at Harvard eventually culminated with Leary and Alpert being fired from the university.

This was a pivotal event that ignited the 1960s psychedelic revolution and counter culture movement, but a regrettable side effect of this was the political backlash against psychedelics, which had them classified as Schedule 1 substances, or Class A this side of the pond. This dramatically and suddenly halted all scientific research into substances otherwise considered to have been showing substantial promise in many areas and certainly worthy of scientific attention. From the government crackdown of the middle 60’s, it is only now, half a century later that the scientific taboo of researching these compounds is beginning to thaw slightly.


 
 Aldous Huxley


While not a scientist, but having a strong interest in the sciences, writer Aldous Huxley was heavily influenced by his psychedelic experiences, and he made some highly perceptive observations of the psychedelic state that modern science is now beginning to validate. In his famous mescaline trip, documented in his book The Doors of Perception and Heaven and Hell, he formulates a hypothesis of psychedelics acting via reducing the filtering valves of the brain (Huxley 1954). Half a century on from Huxley’s psychedelic musings, cutting edge neuroscience employing detailed fMRI brain imaging is confirming such a view, with psilocybin found to reduce blood flow to certain control hubs in the brain, which act to filter sensory information (Carhart-Harris et al. 2011). When asked about who should use psychedelics and why, Huxley had the following to say:

“…I think the people who would benefit most of all are professors. I think it would be extremely good for almost anybody with fixed ideas and with a great certainty about what’s what to take this thing and to realize the world he’s constructed is by no means the only world, that there are these extraordinary other types of universe.”

Dr John Lilly, physician, neuroscientist, psychoanalyst and philosopher was an expert in electronic brain stimulation, brain mapping, human-dolphin communication and the inventor of the isolation tank. His thinking was heavily influenced by his psychedelic drug use. The isolation tank comprises an enclosed space in pitch blackness and silence and warm salty water to allow floatation, so sensory input is absolutely minimised, so magnifying one’s ability to explore their inner space while free of any external distractions.

In the early 1960’s, Lilly was an early pioneer in charting the inner space of the human mind, taking large doses of LSD and having consciousness and metaprogramming exploration sessions in his tank, with the ultimate intention of reprogramming his mental circuits towards self-realization. Later, he switched to ketamine, after being introduced to the drug by Dr Craig Enright. After being cured of his frequent migraines through use of the drug, Lilly became obsessed and would take large quantities of ketamine with alarming frequency, being committed to a few psychiatric hospitals for brief episodes and experiencing two near fatal accidents while intoxicated. Lilly was undoubtedly brilliant but was well known for his eccentricity.

The scientific field of psychopharmacology was largely founded on research into psychedelics. The finding that chemicals could profoundly alter consciousness, and by extension were intimately tied to consciousness, dramatically altered the previous scientific view preceding the 1950’s, that brain activity was largely down to electrical activity. The close resemblance in the chemical structure of key neurotransmitter serotonin and LSD helped to cement this new view of chemistry playing a key role in brain activity. British pharmacologist Sir John H. Gaddum led a team in Edinburgh that discovered serotonin in the brain. On four separate occasions in 1953, Gaddum ingested LSD to study its effects in the first-person (Green 2008). He was the first person to postulate a relationship between LSD and serotonin, and on LSD’s influence on serotonin function being responsible for LSD’s psychedelic effects (Gaddum 1953). On this matter he went on to write the following: “The evidence for the presence of HT [serotonin] in certain parts of the brain may be used to support the theory that the mental effects of lysergic acid diethylamide are due to interference with the normal action of this HT.” (Amin et al. 1954).

Not only was this evidence of a fledgling pharmacological neuroscience in the making, but it was a highly perceptive observation that more recent psychedelic research has confirmed, which has highlighted the importance that serotonin receptors play in the production of psychedelic effects in the brain following psychedelic ingestion (Glennon et al., 1984; Lyon et al., 1988; Titeler et al. 1988).

Mathematician Ralph Abraham has been heavily influenced by use of psychedelics. Abraham was turned onto LSD by one of his students while at Princeton, and in 1969 experienced DMT for the first time. Abraham’s first experience with LSD ignited a lifelong fascination with the exploration of consciousness, and five years of inner and outer world travels. These explorations would have a profound aspect on all aspects of his life. His 1969 encounter with DMT played a pivotal role in is mathematical understanding of chaos theory and consciousness, based on geometry, topology, nonlinear dynamics and the theory of vibrating waves. Abraham states that psychedelics forever shifted his academic focus from that of pure mathematics to a more experimental and applied study of vibrations and forms. Psychedelics likely had a profound influence on the development of both chaos theory and fractal geometry (Abraham 2008).

Biochemist Dr Kary Mullis is open about his past LSD use, and considers his use of the compound to have played a major role in his visualising the mechanism of the Polymerase Chain Reaction (PCR), for which he was awarded the Nobel Prize in Chemistry in 1993. PCR is a technique used in molecular biology to amplify a single copy or a few copies of a segment of DNA by many orders of magnitude, generating thousands to millions of a particular DNA sequence in a short time. It is considered an often indispensable technique for medical and biological research for a variety of different applications. A crucial part of Mullis’s description, which follows, is that his insight came after his use of LSD. This boost to creative thinking following a psychedelic session was reported by scientists and engineers in the one and only study looking at psychedelics and creative problem solving in this group as shall be discussed.

“PCR’s another place where I was down there with the molecules when I discovered it and I wasn’t stoned on LSD, but my mind by then had learned how to get down there. I could sit on a DNA molecule and watch the [indistinct] go by…I’ve learned that partially I would think, and this is again my opinion, through psychedelic drugs…if I had not taken LSD ever would I have still been in PCR? I don’t know, I doubt it, I seriously doubt it.” (Mullis 1998).

Some sources state that Francis Crick’s use of LSD inspired visions of the DNA molecule. Such claims are false however. Crick and Watson’s famous discovery of the double helix of DNA came in 1953, with LSD only having been discovered ten years previously. It was still at this point rare and little known, and it was highly unlikely that the then impoverished and conventional Crick would have encountered it previous to this time. According to first-hand information from Crick’s biographer Matt Ridley obtained directly from Crick’s widow, Crick’s first encounter with LSD came in 1967, when he was gifted some by friend Henry Todd, many years after his shared discovery of the structure of DNA. While LSD may well have augmented Crick’s scientific contemplations, his major breakthroughs in molecular biology were all made previous to 1967.

The late, great psychopharmacologist Dr Alexander “Sasha” Shulgin was deeply inspired by his first ever psychedelic experience, with mescaline in the late 1950’s. From the experience, Shulgin understood “that our entire universe is contained in the mind and the spirit. We may choose not to find access to it, we may even deny its existence, but it is indeed there inside us, and there are chemicals that can catalyze its availability.”

Enlight by R. Ayana
This experience ignited in Shulgin a lifelong fascination in psychedelic chemistry; of the synthesis and experience of ingesting psychedelic compounds, comprising the two dominant chemical families of classical psychedelics, the tryptamines and phenethylamines, of which he synthesised and bioassayed over 230 different kinds. With Shulgin’s passing, his work and his creations live on and will continue to influence people’s consciousness far into the future.

The late, great chemist Dr Albert Hofmann had a spontaneous experience of a mystical nature as a young boy while out walking in the countryside, experiencing a joy and profound connection to nature. He stated “…my mystical experience of nature as a child…was absolutely like an LSD-experience…. I believe I was in some fashion born to that.” (Hofmann 2009). Hofmann’s invention and discovery is also mysterious. LSD was the 25th in a series of compounds synthesised from the ergot fungus (Claviceps purpurea) and at the time he was looking for a respiratory stimulant. After animal testing hadn’t revealed anything that suggested it held much promise in this regard, it was shelved for five years. Hofmann had a strange dream where the essence of LSD suggested he hadn’t seen all that it was capable of, and he had a feeling his work was not yet done with it (Hofmann 2009). Most scientists would have dismissed this, but Hofmann heeded this call of intuition. On April 16th 1943, he decided to synthesise a batch for testing. During this procedure he inhaled some or absorbed some through his fingers, and for two hours experienced clear psychedelic effects.

This two hour experience itself is very unusual and unheard of when it comes to all subsequent LSD experiences which tend to be much longer lasting, even at threshold doses. LSD expert Dr David Nichols has suggested Hofmann may have had another spontaneous mystical experience that happened to coincide with his discovery. Whatever the case, it seems Hofmann had an exquisite sensitivity to the effects of LSD, and along with his previous illuminating childhood experiences, it seems he was the right person in the right place at the right time to discover it. Three days later on April 19th, being a cautious man, Hofmann tested on himself what he thought would be a microscopic dose of 250 micrograms, and the rest, as they say, is history. Hofmann’s discovery shows that scientific breakthroughs don’t always come gradually via the standard methodological deduction process, but can occur as a sudden, intuitive or irrational flash of inspiration, like the fabled “Eureka” moment.

Hofmann is not the only scientist working with psychedelics to have been inspired by his dreams. Professor Steven Barker is a specialist in neurotheology and an expert on DMT. From a young age, Barker experienced highly vivid dreams, and at times dreams he’d later to come to know as having a psychedelic, hallucinatory aspect. Not content with the religious interpretation for such experiences, Barker was passionate about finding objective explanations, and this ultimately set him on a path that led him to devoting his life to researching altered states and psychedelics. On the subject of dreams, Barker stated that of “…all the myriad aspects of this still miraculous phenomenon called consciousness, I was and remain most fascinated and influenced by the experience of dreams. For me, dreaming was the first memorable journey into an altered state, traveling to what seemed, at the time, a separate reality.”

The anthropologist Jeremy Narby in his book The Cosmic Serpent explores this link between ayahuasca shamanism and molecular biology. Narby conducted two years of fieldwork in the Peruvian Amazon researching the ecology of the Ashánika tribe. He hypothesises that shamans may have access to information on the molecular level via their ingestion of ayahuasca (Narby 1995) and shamanism concerns “attempting to dialogue with nature” (Narby 2006). He accompanied three molecular biologists to the Amazon where they experienced an ayahuasca ceremony. While all three found the experience to be personally meaningful, experiencing the ayahuasca as an entity distinct from themselves, two of the three gained perspectives on their research they considered valuable following the session (Grant 2006).

Psychedelics may have also played a major role in the advent of modern computing. Both Bill Gates and Steve Jobs are known to have experimented with LSD. While Gates has been tight lipped regarding the nature of his experiences with the compound, Jobs has been much more open, positively referring to his experiences with LSD “as one of the two or three most important things he had done in his life” (Markoff 2005). Douglas Engelbart, the visionary who first proposed that we use computers to communicate and collaborate in a networked world, and introduced a score technical innovations, including videoconferencing, hyperlinks, networked collaboration, digital text editing, and the mouse, also found LSD to be beneficial. He experienced LSD under guided sessions provided by the International Foundation for Advanced Study (IFAS) under the only study looking at psychedelics and scientific creativity to be performed thus far. There is definitely a strong link between psychedelic use and the personal computing revolution, with Silicon Valley’s rise to the hub of the technology industry coinciding with the cultural explosion of LSD and other psychedelics. The full extent of this link remains unknown due to the political stigmatising of psychedelics and their use.

The concept of Deep Ecology, originally proposed by Norwegian philosopher Arne Næss, is very much in line with the psychedelic pantheist view of nature which views all life forms as having an inherent worth regardless of their usefulness to human needs. Both Næss and John Seed, another founding father of the Deep Ecology movement, were certainly inspired by their own use of LSD. In 1966 writer and former Merry Prankster Stewart Brand imagined perceiving the Earth from space in the midst of an LSD experience, and this inspired him to campaign for a photograph of the Earth to be taken from space, which it was in the year or two following, from both a satellite in orbit and from the moon. These images would be powerful symbols of the ecology movement, showing just how beautiful, alive and unique our planet is. John P. Allen, the inventor and Director of Research of Biosphere 2, the largest laboratory of global ecology in the world, was profoundly inspired by a Peyote ceremony experienced in a traditional setting with Huichol Indians. Mark Van Thilo, whose responsibility in the dome was to maintain the technical systems, was also influenced by his own experiences with psychedelics, and had a profound desire to link ecology with technology, perceiving no difference between the two. 

The description of the first ayahuasca experience of leading ethnopharmacologist Dr Dennis McKenna is a particularly eloquent and beautiful tribute to the profound ability of ayahuasca to connect us to the Earth. McKenna described seeing the Amazon from above the Earth, with the ayahuasca vine growing up towards him, the experience of the ayahuasca as a sentient plant intelligence. He experienced things from the point of view of a sentient water molecule, being drawn up into an Amazonian tree, and vividly experiencing photosynthesis. This was a profoundly moving and humbling experience, and sometime later he found himself once more above the Amazon, and was filled with an intense sadness, rage and shame at its destruction at human hands. At this point a quiet voice from behind his left shoulder said to him “You monkeys only think you’re running things. You don’t think we would really allow this to happen do you?” Dennis felt this voice represented the sum total of all species in the planetary biosphere (McKenna 2012). Such experiences with an ecological message seem to be commonly associated with ayahuasca.

Recent research using data comprising hundreds of thousands of people who have used psychedelics has found no link between psychedelic use and mental health issues, and in fact observed less cases of psychiatric hospital visits and suicides. The scientists who led the studies concluded that there was no reason for making psychedelics illegal on public health grounds, and in fact it should be against human rights for them to be illegal, and at the very least their current legal status should be urgently reconsidered (Hendricks et al. 2015; Johansen & Krebs 2015). Therapeutic and medicinal properties of psychedelics aside, by classifying them as Class A substances, without good reason, we could be denying people working in the fields of science and technology, in the creative arts and in other fields a set of profound tools that could be being integrated and used for creative expansion for the benefit of humanity. Given that our creative skills are essential for tackling all problems we face as a species, and given our ecological position, with the increasing impact we are inflicting upon the biosphere, it may be extremely unwise to deny people access to these tools.

The late Willis Harman performed a pilot study looking at psychedelics and creativity in scientists and engineers along with Myron Stolaroff, James Fadiman and others right before the government backlash ended all psychedelic research in the US and elsewhere, and the study was cut short by DEA intervention (Harman et al. 1966). In the trail, LSD and mescaline were administered to a small group of scientists and engineers in an attempt to boost their problem-solving skills, with each subject instructed to work on a professional problem. The quality of their output was evaluated through psychological tests, subjective reports and the eventual industrial or commercial validation of their finished product. Virtually every subject produced highly satisfactory outputs according to these assessments.

The psychedelics were found to have a highly beneficial effect on scientific creativity, via enhancing the imagination, inspiring novel thought, and boosting problem solving abilities, and some of the scientists reported that following the study their creative problem solving ability remained high in the clear sober light of day. Despite these highly positive initial results, this landmark study remains the one and only scientific investigation using psychedelics to enhance the creative, problem solving process in a scientific and engineering context. With the recent revival in psychedelic research, it is high time that this neglected area of study received the scientific attention it deserves.


Sus_1_grande 

Bibliography


Abraham, R. (2008) Mathematics and the Psychedelic Revolution. MAPS, MS #124.
Amin, A.H., Crawford, T.B. & Gaddum, J.H. (1954) The distribution of substance P and 5-hydroxytryptaime in the central nervous system of the dog. Journal of Physiology (London), 126, 596-618.
Carhart-Harris, R.L., Erritzoe, D., Williams, T. Stone, J.M., Reed, L.J., Colasanti, A., Tyacke, R.J., Leech, R., Malizia, A.L., Murphy, K., Hobden, P., Evans, J., Fielding, A., Wise, R.G. & Nutt, D.J. (2011) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences of the United States of America, 109, 2138-2143.
Gaddum, J.H. (1953) Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine. Journal of Physiology (London), 121, 15.
Glennon, R.A., Titeler, M. & McKenney, J.D. (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences, 35, 2505-2511.
Grant, J. (2006) Discarded Science. Sterling Publishing, p. 185-186.
Green AR (2008). Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK. British Journal of Pharmacology, 154, 1583-1599.
Harman, W.W., McKim, R.H., Mogar, R.E., Fadiman, J. & Stolaroff, M.J. (1966) Psychedelic agents in creative problem solving: A pilot study. Psychological reports, 19, (1), 211-227.
Hendricks, P.S., Thorne, C.B., Clark, C.B., Coombs, D.W. & Johnson, M.W. (2015) Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29, (3), 280-288.
Hofmann, A., Broeckers, M. & Liggenstorfer, R. (2009) Albert Hofmann und die Entdeckung des LSD: Auf dem Weg nach Eleusis, p. 2. AT Verlag.
Hofmann, A. (2009) LSD My Problem Child. 4th Edition. MAPS, Santa Cruz, California.
Huxley, A. (1954) The Doors of Perception and Heaven and Hell. Harper & Brothers.
Johansen, P.-O. & Krebs, T.S. (2015) Psychedelics not linked to mental health problems or suicidal behaviour: A population study. Journal of Psychopharmacology, 29, (3), 270-279.
Lyon, R.A., Titeler, M., Seggel, M.R. & Glennon, R.A. (1988) Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. European Journal of Pharmacology, 145, 291-297.
Markoff, J. (2005) What the Dormouse Said: How the Sixties Counterculture Shaped the Personal Computer Industry. Penguin Publishing Group, New York, US.
McKenna, D. (2012) The Brotherhood of the Screaming Abyss. North Star Press of St. Cloud Inc., Clearwater, Minnesota, US.
Mullis (1997) Horizon: Psychedelic Science. [TV Programme]. BBC, 27 February 1997.
Narby, J. (1999) The Cosmic Serpent: DNA and the Origins of Knowledge. Phoenix.
Narby, J. (2006) Intelligence in Nature. Jeremy P. Tarcher, p. 16.
Titeler, M., Lyon, R.A. & Glennon, R.A. (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology (Berl), 94, 213-216.




For more information about psychedelics see http://nexusilluminati.blogspot.com/search/label/entheogens
- Scroll down through ‘Older Posts’ at the end of each section


Hope you like this not for profit site -
It takes hours of work every day by a genuinely incapacitated invalid to maintain, write, edit, research, illustrate and publish this website from a tiny cabin in a remote forest
Like what we do? Please give anything you can -  
Contribute any amount and receive at least one New Illuminati eBook!
(You can use a card securely if you don’t use Paypal)
Please click below -



Spare Bitcoin change?





For further enlightening information enter a word or phrase into the random synchronistic search box @ the top left of http://nexusilluminati.blogspot.com


And see


 New Illuminati on Facebook - https://www.facebook.com/the.new.illuminati

New Illuminati Youtube Channel -  https://www.youtube.com/user/newilluminati/playlists

New Illuminati’s OWN Youtube Videos -  
New Illuminati on Google+ @ For New Illuminati posts - https://plus.google.com/u/0/+RamAyana0/posts

New Illuminati on Twitter @ www.twitter.com/new_illuminati


New Illuminations –Art(icles) by R. Ayana @ http://newilluminations.blogspot.com

The Her(m)etic Hermit - http://hermetic.blog.com



DISGRUNTLED SITE ADMINS PLEASE NOTE –
We provide a live link to your original material on your site (and links via social networking services) - which raises your ranking on search engines and helps spread your info further!

This site is published under Creative Commons (Attribution) CopyRIGHT (unless an individual article or other item is declared otherwise by the copyright holder). Reproduction for non-profit use is permitted & encouraged - if you give attribution to the work & author and include all links in the original (along with this or a similar notice).

Feel free to make non-commercial hard (printed) or software copies or mirror sites - you never know how long something will stay glued to the web – but remember attribution!

If you like what you see, please send a donation (no amount is too small or too large) or leave a comment – and thanks for reading this far…

Live long and prosper! Together we can create the best of all possible worlds…


From the New Illuminati – http://nexusilluminati.blogspot.com

Sunday, 21 September 2014

The Return of LSD Research

.The Return of LSD Research
Dr Robin Carhart-Harris is the first scientist in over 40 years to test LSD on humans - and you're next


 

The scientist talks to Laurence Phelan about fighting the establishment, battling preconceptions and breaking down egos

 


 


On a hot evening in June, in a crowded room above a London pub, Dr Robin Carhart-Harris, a research associate in the Centre for Neuropsychopharma-cology at Imperial College, is giving a public talk about his work. He is having to make himself heard over the boozy commotion downstairs, where people are watching Chile put Spain out of the World Cup. But there is a slightly giddy atmosphere in the function room, too, because the doctor's area of research is as exciting as it is taboo: he is investigating the brain effects and potential therapeutic uses of psychedelic drugs.

http://www.independent.co.uk/incoming/article9672844.ece/alternates/w620/v25725581.jpgCarhart-Harris is the first person in the UK to have legally administered doses of lysergic acid diethylamide (LSD) to human volunteers since the Misuse of Drugs Act of 1971, and his presentation climaxes with a slide showing something no one else has seen before: an as-yet unpublished cross-sectional image of the brain of a volunteer who was in an fMRI scanner while tripping on acid. Blobs of colour indicate changes in blood flow, from which can be inferred changes in levels of activity in specific brain regions – notably, in this case, the hippo-campus, which is involved, among other things, in making memories and giving them context.

"We've only looked in six brains so far," says Carhart-Harris when we meet a couple of weeks later in a coffee shop near his flat in Notting Hill. Born in Durham 33 years ago and raised in Bournemouth, he has an indie haircut and looks a bit like he could be the celebrity physicist Brian Cox's cooler younger brother. He is a careful and articulate speaker, but his enthusiasm for his work is evident. "We're at an early, but certainly promising, stage. It's really exciting," he says.

The potential scientific benefits of psychedelics (as distinct from whatever cultural, social, artistic, spiritual or subjectively enjoyable benefits one might also argue they have) fall broadly into two categories. They look like being medicinally or therapeutically useful, and they offer an unconventional view of the workings of the human mind, such that the age-old, so-called "hard problem of consciousness" might be made a little easier. The etymology of the word "psychedelic" is, after all, from the Greek for "mind-revealing".

Plant-derived psychedelics such as mescaline (from the peyote cactus), DMT (from the root of the ayahuasca vine) and psilocybin (magic mushrooms) have been used therapeutically and medicinally for millennia. In 1943, however, Albert Hofmann, a 37-year-old Swiss chemist in the laboratories of the pharmaceutical company Sandoz in Basel, accidentally ingested – through his fingertips – a chemical he had synthesised from the ergot fungus, and became the first person to experience its remarkable mind-altering properties. Interviewed shortly before his 100th birthday, he called LSD "medicine for the soul".

Uniquely potent in minute doses, and with what Carhart-Harris calls "a very favourable physiological safety profile" – which is to say, it is non-toxic – this newly synthesised psychedelic drug opened new doors, in more ways than one. "You could say the birth of the science of psychedelics occurred with the discovery of LSD," says Carhart-Harris. "It was only then that we started to study them systematically."

By 1947, Sandoz was promoting LSD, under the brand name Delysid, as an adjunct to psychotherapy. Cary Grant famously used it during his therapy, as did the Alcoholics Anonymous co-founder Bill Wilson. Between the 1950s and 1965, when Sandoz withdrew the drug, there were more than 1,000 clinical papers discussing 40,000 patients. A 2012 meta-analysis of six controlled trials from the era found its clinical efficiency for the treatment of alcohol addiction to be as effective as any treatment developed since.

"I personally think it has a great deal of potential for treating addiction," says Carhart-Harris. "It's slightly hypothetical, but it's based on what we know about the way the brain works, which is that it settles into configurations of activity that seem to underly certain psychopathologies.

"Depression and addictions rest on reinforced patterns of brain activity, and a psychedelic will introduce a relative chaos. Patterns that have become reinforced disintegrate under the drug. I've used the metaphor of shaking a snowglobe. And there's some evidence that psychedelics induce plasticity, in terms of neural connections in the brain, such that there is a window of opportunity in which connections can either be broken or reinforced. New things can be learnt at the same time that old things can be unlearnt. It induces a kind of suppleness of mind."

The biological mechanisms that underlie the psychedelic experience were unknowable in the 1950s and 1960s, prior to the modern era of neuroscience and brain imaging. "Rather than testing whether a drug works, finding that it seems to, and then trying to understand how, I prefer the way we're doing it now," says Carhart-Harris. "It's a bit more logical and cautious."

Caution, readers might be pleased to note, is a watchword throughout our conversation. "The dangers with psychedelics – and there are potential dangers," says the doctor, " arise when they are taken without the proper caution. The model for how the drugs are taken therapeutically is very different from how people might take them recreationally. People are in a particularly sensitive and vulnerable state on psychedelics, and I do think you need that professionalism and structure to have it done properly."

http://www.independent.co.uk/incoming/article9672845.ece/alternates/w460/5725582.jpg
.Albert Hofmann's 1980 book traces LSD’s path from a promising research medicine to a recreational drug that sparked hysteria (Kalpesh Lathigra)


The doses Carhart-Harris administers are lower than a recreational user might typically take, but if anything the volunteers' experiences would seem to be more vivid. "When people take psychedelics recreationally, in a social context," he says, "they might get preoccupied by the perceptual changes and the novelty, and they'll laugh their way through with a certain amount of confusion and anxiety. But in an experimental context, particularly in the therapeutic context, people lie on a couch with their eyes closed and have a very introspective experience. It's richer; psychologically, it's more interesting.


Without distractions, emotions and memories are more likely to emerge spontaneously. There is a possibility of having quite vivid recollections of past experiences, such that they're not past any more and can be re-experienced in the present. It gets very interesting when people start describing where they're going in their minds. It's the kind of stuff you just wouldn't hear ordinarily."

Music is used in both the therapeutic and the brain-imaging studies. "People typically play classical music in psychedelic-assisted psychotherapy," says Carhart-Harris, "But we're going with some relaxing ambient stuff, particularly in the setting of a noisy MRI scanner. We're also looking at the interaction between music and LSD; seeing whether emotional arousal and ego dissolution are enhanced. The theory – and it k is only a theory because it's never been tested until now – is that the music can do a number of things. It can have a steadying influence, but it can also help facilitate emotional release."

The subjects, who have mostly been men – "We need more female volunteers," says Carhart-Harris – have largely reported positive experiences. But, he adds, "We've had some tears, some people who've been anxious and at least one who hasn't enjoyed it." One subject recalled a relationship break-up, which was "melancholic but also moving, and not necessarily negative".

Last month, the Daily Mail reported on Carhart-Harris's research into psilocybin and its potential for treating depression. I suggest that the comments below the article ("Duh, but your brain will be fried and later on you'll be stupid" or "How can you be depressed if you're dead or in a mental institution?") might offer a representative sample of commonly held fears. But Carhart-Harris isn't sure. "That's an example of primitive thinking, really, where instead of being rational and assessing the evidence, one is biased by one's emotions – in this case, one's fear about the unknown."

Having said that, "There have been some cases in the past of psychosis being induced by psychedelics. More so when the drugs are taken recreationally. It hasn't happened in modern trials, but it was reported in a few cases in the 1960s. We recruit only people who have previous experience with psychedelics. If our main aim is to find out how the drugs work in the brain, we may as well play on the safe side and get volunteers who've previously tolerated them."

LSD is a Schedule I drug under the 1971 UN Convention of Psychotropic Drugs, and a Schedule I, Class A drug under the UK Misuse of Drugs Act. But this categorisation, which both earns the drug its forbidding reputation and hinders research into it, is something of a historical accident rather than an accurate reflection of the dangers it poses.

Robin Carhart-Harris in his office, where he is investigating the loss of sense of self induced by psychedelics
Robin Carhart-Harris in his office, where he is investigating the loss of sense of self induced by psychedelics (Kalpesh Lathigra)


Heroin, for example, is a lesser, Schedule II drug under the 2001 Amendment to the UK Act, because while it is more dangerous than LSD and has a high potential for abuse, its usefulness as a pain medication had long been recognised. To stock LSD, which was deemed not to have any medical uses, on the other hand, requires a licence from the Home Office. Such licences have been prohibitively expensive and time-consuming for researchers to obtain; only four have ever been granted. You also have to find a lab willing and able to manufacture the drug, and there are similarly few of them, for the same reasons.


Professor David Nutt, the director of the Neuropsychopharmacology Unit where Carhart-Harris is doing the research ("The buck stops with me, but Robin's doing all the legwork and I'm just taking the credit," he says), has written extensively about the wrong-headedness of the current drug laws. "It is absurd to treat LSD and psilocybin as more dangerous than heroin," he tells me. In a 2010 study published in The Lancet, following on from the work that led to his controversial sacking from the chair of the Government's Advisory Council on the Misuse of Drugs the year before, Professor Nutt ranked the 20 most commonly used drugs according to the evidence for the overall amount of harm they do to the users and to society. Psilocybin came last, with an overall harm score of six, and LSD came 18th with a score of seven, compared with alcohol's 72 and heroin's 55.

When I ask why LSD was prohibited, he has a surprisingly simple three-word answer: "the Vietnam war". Essentially, when its use spread to the general population in the mid 1960s, "Young Americans realised they didn't want to fight any more. That brought a huge tension into society. So they had to create reasons for banning the drug. Everyone knew the arguments were totally specious. But no one stood up."

Carhart-Harris has a further explanation: "Psychedelics are scary because they reveal the mind, and people are scared of their own minds. They're scared of the human condition, really."

The brain and mind both have a hierarchical structure, and what Freud intuited and neuroscience has confirmed is that a significant portion of our mental activity occurs at levels other than the one at which your normal, waking, conscious self – your ego – is operating. As a result and by their very nature, these unconscious processes have traditionally been hard to investigate. But the non-normal consciousness that psychedelics induce is characterised by a dissolution of the ego; a loss of the sense of self. "That is why they are so valuable as tools to understand the mind," says Carhart-Harris. "This division between the ego-intact mode of consciousness and a mode which is more primitive breaks down, so you can begin to observe the unconscious mind."

No wonder the Czech psychiatrist Stanislav Grof, in 1975, predicted that "psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology or the telescope is for astronomy". Unfortunately, the effective prohibition of LSD research meant it was not to be. Perhaps Professor Nutt has Grof in mind when he says: "I think it's the worst censorship of research since the Catholic Church banned the telescope." He continues: "There's a lot of evidence for LSD being an efficacious treatment for things such as addiction. But no one's done a study on it for 50 years. This is outrageous."

Dr Carhart-Harris says: 'Criminalising these substances doesn't help anyone. Historically they've benefited mankind'
Dr Carhart-Harris says: 'Criminalising these substances doesn't help anyone. Historically they've benefited mankind' (Kalpesh Lathigra)


Perhaps because he sees such potential in them, or perhaps because he suffered the latest in a line of funding knock-backs in the week that we meet, Carhart-Harris sounds somewhat peeved that psychedelics remain an outsider scientific interest. "I've been going for 10 years and done a lot of, I think it's fair to say, quite pioneering research. But it does feel as though there's some kind of conservative resistance k to it. People may claim to be supportive of novel research, but are they really?" he wonders.


Psychedelics certainly have their devotees. One such is Amanda Feilding, Countess of Wemyss and March, who in 1998 founded the Beckley Foundation, a charitable trust with the twin aims of initiating and conducting research into psychedelics, and effecting changes to global drugs policy. The foundation has provided a major part of the funding for the LSD study. "She has been critical to our progress," says Carhart-Harris, "and consistent in her support."

"I've been wanting to do this research for 20 years," Feilding tells me – and adds that she had personally promised Albert Hofmann she would get an LSD study off the ground in the modern era and in his lifetime. ("He was truly delightful. Very small, but a remarkable giant of a man." Unfortunately he died in 2008, aged 102.)

"I thought it essential to break the taboo on these substances," Feilding explains. "And hopefully, slowly, by doing good work with the very best experts on both policy and science, we can build up an evidence base which will inform people that these substances have potential benefits, and that criminalising them doesn't help anyone. Because historically they had always benefited mankind. They used to be sacraments, they were termed the flesh of the gods but now they're [considered] the substance of the devil."

Feilding "has been quite a lone voice, really", says Carhart-Harris, which means he also has to consider other sources of research funding. "I'm now thinking about crowd-funding," he says. "There's so much enthusiasm out there: I get inundated with emails from people telling me that they believe in its potential."

That potential is becoming clear, yet the barrier to progress is not scientific but legal, and depends on political will. "It's very easy to get caught up in the optimism of it all," says Carhart-Harris, "but the more psychedelics become visible, the more likely it is that there's going to be some kind of conservative reaction to them.

"Psychedelics are polarising, and people are opposed to them because they're threatening. But science is an exercise in honesty, really. That's its great merit. And if you want to understand reality better, then you have to confront things that might be difficult."

For more information and to donate towards the research: http://psychedelicscience.org.uk


A trip through time: The history of LSD

19 April 1943

http://graphics8.nytimes.com/images/2008/04/30/world/hoffman02450.jpg


Having accidentally ingested LSD three days earlier, Albert Hofmann takes the world's first intentional acid trip and rides home from the lab on his bike. The event is commemorated annually on "Bicycle Day"

May 1950


The first article about LSD appears in the American Journal of Psychiatry

13 April 1953


The CIA initiates the MKULtra Project to investigate LSD's potential as a mind-control drug


22 November 1963
 
Aldous Huxley, author of The Doors of Perception, instructs his wife to administer him with LSD on his deathbed, and passes away "very, very gently"


Summer 1964

Ken Kesey and the Merry Pranksters drive across America in a bus called Further, and throw the parties chronicled in Tom Wolfe's The Electric Kool-Aid Acid Test


April 1965



The Beatles are introduced to acid by George's dentist. Sgt. Pepper's Lonely Hearts Club Band comes out in June 1967, and while John denies "Lucy in the Sky with Diamonds" was an intentional expansion of "LSD", few believe him


14 January 1967



Four years after he is sacked from the psychology department at Harvard, acid evangelist Dr Timothy Leary tells a 30,000-strong gathering at the Human Be-In in San Francisco to, "Turn on, tune in, drop out"


21 February 1971

The UN Convention on Psychotropic Substances makes LSD illegal in its 183 signatory nations



From The Independent @ http://www.independent.co.uk/news/people/dr-robin-carhartharris-is-the-first-scientist-in-over-40-years-to-test-lsd-on-humans--and-youre-next-9667532.html


For more information about psychedelics see http://nexusilluminati.blogspot.com/search/label/entheogens
- Scroll down through ‘Older Posts’ at the end of each section


Hope you like this not for profit site -
It takes hours of work every day by a genuinely incapacitated invalid to maintain, write, edit, research, illustrate and publish this website from a tiny cabin in a remote forest
Like what we do? Please give anything you can -  
Contribute any amount and receive at least one New Illuminati eBook!
Please click below -



Videos @  http://youtu.be/wRnAcVLBIyY?list=PLF3831B591D7DC64F
http://youtu.be/sBpjUHKXNhI
 


For further enlightening information enter a word or phrase into the random synchronistic search box @ the top left of http://nexusilluminati.blogspot.com


And see


 New Illuminati on Facebook - https://www.facebook.com/the.new.illuminati

New Illuminati Youtube Channel - http://www.youtube.com/user/newilluminati/feed


New Illuminati on Twitter @ www.twitter.com/new_illuminati


New Illuminations –Art(icles) by R. Ayana @ http://newilluminations.blogspot.com

The Her(m)etic Hermit - http://hermetic.blog.com


The Prince of Centraxis - http://centraxis.blogspot.com (Be Aware! This link leads to implicate & xplicit concepts & images!)



DISGRUNTLED SITE ADMINS PLEASE NOTE –
We provide a live link to your original material on your site (and links via social networking services) - which raises your ranking on search engines and helps spread your info further! This site is published under Creative Commons Fair Use Copyright (unless an individual article or other item is declared otherwise by the copyright holder). Reproduction for non-profit use is permitted & encouraged,  - if you give attribution to the work & author. Please include a (preferably active) link to the original (along with this or a similar notice).

Feel free to make non-commercial hard (printed) or software copies or mirror sites - you never know how long something will stay glued to the web – but remember attribution!

If you like what you see, please send a donation (no amount is too small or too large) or leave a comment – and thanks for reading this far…

Live long and prosper! Together we can create the best of all possible worlds…


From the New Illuminati – http://nexusilluminati.blogspot.com